Overweight and Obesity Clinical Trial
— MIND-EATOfficial title:
Validation of a Mindful Eating Program Adapted to the French Population Living With Overweight or Obesity
The aim of this project is to validate a new mindful eating programme adapted to the overweight or obese French population. Recognising the importance of diet in the management of chronic diseases, particularly obesity, and the limitations of traditional weight management approaches, the study focuses on the application of mindful eating. The investigators have adapted a model based on an existing eating disorders programme overseas, taking into account feedback from participants in a qualitative study and the scientific literature. The ultimate aim is to test and validate the effectiveness of this new programme in improving the care of overweight or obese French adults, thereby filling a gap in interventions for this population in France.
Status | Recruiting |
Enrollment | 56 |
Est. completion date | October 17, 2024 |
Est. primary completion date | October 16, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - First visit to the Nutrition and Diabetes Unit of Montpellier University Hospital for overweight/obesity - Adults aged 18 and over, volunteers - BMI = 25kg/m² and = 50kg/m² - Provisional verbal consent followed by signed written consent Exclusion Criteria: - People who are illiterate or suffer from a major cognitive impairment that prevents them from understanding the study and the mindful eating program - Pregnant or breast-feeding women - People who are taking medicines that may have an effect on their weight (especially GLP-1 analogs, neuroleptics, corticosteroids) - Anyone with a history of bariatric surgery or scheduled bariatric surgery within the next 6 months - Presence of co-morbidities or severe pathologies (in particular respiratory failure, heart failure, cancer) - Diagnosis of severe psychiatric disorder (in particular schizophrenia, bipolar disorder), depressive syndrome, or suicidal behavior in the past year - People suffering from genetic or syndromic obesity - Lack of Internet access - Person currently participating in another interventional study |
Country | Name | City | State |
---|---|---|---|
France | Antoine Avignon | Montpellier |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Montpellier |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Impact of the program on participants' lives | The focus groups will highlight changes in behavior, points of view, positive or negative experiences, and/or suggestions for improving the program. | 3 months and 3 weeks after the end of the program | |
Primary | Variation in the level of mindful eating. | It will be measured by the Mind-Eat Scale questionnaire. The Mind-Eat Scale is the first questionnaire to provide a total score of the level of mindful eating and is available in French. This questionnaire was developed and validated as part of the Mind-eat project led by our research team, and the corresponding scientific publication is currently being published. | Assess at visit 1 (10 days before program start), visit 2 (7 days after program end) and visit 3 (3 months after program end). | |
Secondary | Variation in anxiety and depression levels. | It will be measured by the Hospital Anxiety and Depression scale (HAD) questionnaire. The HAD scale is a screening instrument for anxiety and depressive disorders. It comprises 14 items rated from 0 to 3. Seven questions relate to anxiety (total A) and seven to depression (total D), giving two scores (maximum score for each = 21).
A score of 0 to 7 means: no symptoms A score between 8 and 10 means: doubtful symptomatology A score of 11 to 21 means: definite symptomatology The higher the score, the more stress and depression are present. |
Assess at visit 1 (10 days before program start), visit 2 (7 days after program end) and visit 3 (3 months after program end). | |
Secondary | Variation in the level of intuitive eating. | It will be measured by the IES-2-French version questionnaire. | Assess at visit 1 (10 days before program start), visit 2 (7 days after program end) and visit 3 (3 months after program end). | |
Secondary | Variation in the level of compulsive eating. | It will be measured by the BES-French version questionnaire. | Assess at visit 1 (10 days before program start), visit 2 (7 days after program end) and visit 3 (3 months after program end). | |
Secondary | Variation in the level of mindfulness. | It will be measured by the FFMQ-French version questionnaire. | Assess at visit 1 (10 days before program start), visit 2 (7 days after program end) and visit 3 (3 months after program end). | |
Secondary | Variation in eating behavior. | It will be measured by the DEBQ-French version questionnaire. | Assess at visit 1 (10 days before program start), visit 2 (7 days after program end) and visit 3 (3 months after program end). | |
Secondary | Variation in physical activity levels. | It will be measured by the Ricci-Gagnon metric questionnaire. | Assess at visit 1 (10 days before program start), visit 2 (7 days after program end) and visit 3 (3 months after program end). | |
Secondary | Variation in stress levels. | It will be measured by the PSS-French version questionnaire. | Assess at visit 1 (10 days before program start), visit 2 (7 days after program end) and visit 3 (3 months after program end). | |
Secondary | Gross weight loss (kg) | It will be measured by a doctor from the Nutrition-Diabetes Department of the Montpellier University Hospital. | Assess at visit 1 (10 days before program start), visit 2 (7 days after program end) and visit 3 (3 months after program end). |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03994419 -
PErioperAtive CHildhood ObesitY
|
||
Recruiting |
NCT05354245 -
Using a Complex Carbohydrate Mixture to Steer Fermentation and Improve Metabolism in Adults With Overweight and Prediabetes (DISTAL)
|
N/A | |
Completed |
NCT03602001 -
Attentive Eating for Weight Loss
|
N/A | |
Recruiting |
NCT06269159 -
The Power of 24-hour: Co-designing Intervention Components
|
||
Completed |
NCT03377244 -
Healthy Body Healthy Souls in the Marshallese Population
|
N/A | |
Completed |
NCT02996864 -
Location-based Smartphone Technology to Guide College Students Healthy Choices Ph II
|
N/A | |
Terminated |
NCT03914066 -
A Group-based Treatment of Overweight and Obesity in Primary Care
|
N/A | |
Completed |
NCT04647149 -
Effects of Early and Delayed Time-restricted Eating in Adults With Overweight and Obesity
|
N/A | |
Completed |
NCT03685656 -
Effect of ANACA3 Slimming Gel on Loss of Abdominal and Thigh Circumferences in Healthy Volunteers
|
N/A | |
Completed |
NCT05051579 -
A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities
|
Phase 2 | |
Completed |
NCT04611477 -
Effect of Synbiotic 365 on Body Composition in Overweight and Obese Individuals
|
N/A | |
Active, not recruiting |
NCT05330247 -
Cut Down on Carbohydrate in the Dietary Therapy of Type 2 Diabetes - The Meal Box Study
|
N/A | |
Completed |
NCT03599115 -
Effects of Inhibitory Control Training in Eating Behaviors
|
N/A | |
Recruiting |
NCT05938894 -
Train Your Brain - Executive Function
|
N/A | |
Recruiting |
NCT06094231 -
Treating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot Study
|
N/A | |
Recruiting |
NCT05987306 -
A Self-compassion Focused Intervention for Internalized Weight Bias and Weight Loss
|
N/A | |
Completed |
NCT03792685 -
Looking for Personalized Nutrition for Obesity/Type 2 Diabetes Mellitus Prevention
|
N/A | |
Completed |
NCT05055362 -
Effect a Honey, Spice-blended Baked Good Has on Salivary Inflammation Markers in Adults: a Pilot Study
|
N/A | |
Completed |
NCT04520256 -
Rapid Evaluation of Innovative Intervention Components to Maximize the Health Benefits of Behavioral Obesity Treatment Delivered Online: An Application of Multiphase Optimization Strategy
|
Phase 2/Phase 3 | |
Completed |
NCT04979234 -
A Single Centre, Prospective Feasibility Study to Evaluate the Efficacy of an Endoluminal-suturing Device (Endomina) on Severe Obstructive Sleep Apnea Syndrome
|
N/A |